Your browser doesn't support javascript.
Can we do for other essential medicines what we are doing for the COVID-19 vaccine?
Murphy, Adrianna; Mbau, Lilian; McKee, Martin; Hanson, Kara; Torreele, Els.
  • Murphy A; Centre for Global Chronic Conditions, Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK adrianna.murphy@lshtm.ac.uk.
  • Mbau L; Kenya Cardiac Society, Nairobi, Kenya.
  • McKee M; Centre for Global Chronic Conditions, Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
  • Hanson K; Department of Global Health and Population, London School of Hygiene and Tropical Medicine, London, UK.
  • Torreele E; Institute for Innovation and Public Purpose, The Bartlett Faculty of the Built Environment, University College London, London, UK.
BMJ Glob Health ; 6(2)2021 02.
Article in English | MEDLINE | ID: covidwho-1090937
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drugs, Essential / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Bmjgh-2021-005158

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drugs, Essential / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Bmjgh-2021-005158